Serious adverse events
|
CYD Dengue Vaccine Group |
Placebo Group |
Total subjects affected by serious adverse events
|
|
|
subjects affected / exposed
|
1765 / 13915 (12.68%) |
911 / 6939 (13.13%) |
number of deaths (all causes)
|
42 |
27 |
number of deaths resulting from adverse events
|
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
|
|
|
Benign Hydatidiform Mole
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Benign Ovarian Tumour
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Benign Pancreatic Neoplasm
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Bone Giant Cell Tumour
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Bone Sarcoma
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Brain Neoplasm Malignant
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Chondrosarcoma
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Chronic Myeloid Leukaemia
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Desmoid Tumour
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Fibroadenoma Of Breast
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Haemangioma Of Skin
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Hodgkin's Disease
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Leukaemia
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Osteochondroma
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Osteoma
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Osteosarcoma Metastatic
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
Osteosarcoma Recurrent
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
Ovarian Adenoma
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Ovarian Germ Cell Teratoma Benign
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Pituitary Tumour Benign
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Thyroid Cancer
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Uterine Leiomyoma
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Vascular disorders
|
|
|
Hypertensive Crisis
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Secondary Hypertension
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Surgical and medical procedures
|
|
|
Abortion Induced
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Abortion Induced Complete
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Caesarean Section
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Cholecystectomy
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Obesity Surgery
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Scoliosis Surgery
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Surgery
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Umbilical Hernia Repair
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Pregnancy, puerperium and perinatal conditions
|
|
|
Abnormal Product Of Conception
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Abortion
|
|
|
subjects affected / exposed
|
14 / 13915 (0.10%) |
6 / 6939 (0.09%) |
occurrences causally related to treatment / all
|
0 / 14 |
0 / 6 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Abortion Complete
|
|
|
subjects affected / exposed
|
9 / 13915 (0.06%) |
4 / 6939 (0.06%) |
occurrences causally related to treatment / all
|
0 / 9 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Abortion Complicated
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Abortion Incomplete
|
|
|
subjects affected / exposed
|
22 / 13915 (0.16%) |
9 / 6939 (0.13%) |
occurrences causally related to treatment / all
|
0 / 22 |
0 / 9 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Abortion Incomplete Complicated
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Abortion Missed
|
|
|
subjects affected / exposed
|
3 / 13915 (0.02%) |
2 / 6939 (0.03%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Abortion Of Ectopic Pregnancy
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Abortion Spontaneous
|
|
|
subjects affected / exposed
|
48 / 13915 (0.34%) |
30 / 6939 (0.43%) |
occurrences causally related to treatment / all
|
0 / 51 |
0 / 34 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Abortion Spontaneous Complete
|
|
|
subjects affected / exposed
|
8 / 13915 (0.06%) |
6 / 6939 (0.09%) |
occurrences causally related to treatment / all
|
0 / 8 |
0 / 6 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Abortion Spontaneous Complicated
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Abortion Spontaneous Incomplete
|
|
|
subjects affected / exposed
|
16 / 13915 (0.11%) |
2 / 6939 (0.03%) |
occurrences causally related to treatment / all
|
0 / 16 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Abortion Spontaneous Incomplete Complicated
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Abortion Threatened
|
|
|
subjects affected / exposed
|
14 / 13915 (0.10%) |
3 / 6939 (0.04%) |
occurrences causally related to treatment / all
|
0 / 14 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Amniorrhexis
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Antepartum Haemorrhage
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Blighted Ovum
|
|
|
subjects affected / exposed
|
11 / 13915 (0.08%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 11 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Cephalo-Pelvic Disproportion
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Cervical Incompetence
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Complication Of Delivery
|
|
|
subjects affected / exposed
|
4 / 13915 (0.03%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Delivery
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Eclampsia
|
|
|
subjects affected / exposed
|
5 / 13915 (0.04%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Ectopic Pregnancy
|
|
|
subjects affected / exposed
|
3 / 13915 (0.02%) |
3 / 6939 (0.04%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Failed Induction Of Labour
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
False Labour
|
|
|
subjects affected / exposed
|
39 / 13915 (0.28%) |
14 / 6939 (0.20%) |
occurrences causally related to treatment / all
|
0 / 45 |
0 / 14 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Foetal Distress Syndrome
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
4 / 6939 (0.06%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Gestational Hypertension
|
|
|
subjects affected / exposed
|
12 / 13915 (0.09%) |
7 / 6939 (0.10%) |
occurrences causally related to treatment / all
|
0 / 12 |
0 / 7 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Hellp Syndrome
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
High Risk Pregnancy
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Hyperemesis Gravidarum
|
|
|
subjects affected / exposed
|
3 / 13915 (0.02%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Intra-Uterine Death
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
3 / 6939 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Intrapartum Haemorrhage
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Oligohydramnios
|
|
|
subjects affected / exposed
|
12 / 13915 (0.09%) |
4 / 6939 (0.06%) |
occurrences causally related to treatment / all
|
0 / 12 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Placental Insufficiency
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Postpartum Haemorrhage
|
|
|
subjects affected / exposed
|
8 / 13915 (0.06%) |
5 / 6939 (0.07%) |
occurrences causally related to treatment / all
|
0 / 8 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Pre-Eclampsia
|
|
|
subjects affected / exposed
|
34 / 13915 (0.24%) |
23 / 6939 (0.33%) |
occurrences causally related to treatment / all
|
0 / 35 |
0 / 23 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Premature Baby
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Premature Delivery
|
|
|
subjects affected / exposed
|
6 / 13915 (0.04%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 6 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Premature Labour
|
|
|
subjects affected / exposed
|
17 / 13915 (0.12%) |
6 / 6939 (0.09%) |
occurrences causally related to treatment / all
|
0 / 17 |
0 / 6 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Premature Rupture Of Membranes
|
|
|
subjects affected / exposed
|
13 / 13915 (0.09%) |
2 / 6939 (0.03%) |
occurrences causally related to treatment / all
|
0 / 13 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Premature Separation Of Placenta
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Prolonged Labour
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
3 / 6939 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Puerperal Pyrexia
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Retained Placenta Or Membranes
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
2 / 6939 (0.03%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Retained Products Of Conception
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Ruptured Ectopic Pregnancy
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Stillbirth
|
|
|
subjects affected / exposed
|
6 / 13915 (0.04%) |
5 / 6939 (0.07%) |
occurrences causally related to treatment / all
|
0 / 6 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Threatened Labour
|
|
|
subjects affected / exposed
|
7 / 13915 (0.05%) |
9 / 6939 (0.13%) |
occurrences causally related to treatment / all
|
0 / 7 |
0 / 10 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
General disorders and administration site conditions
|
|
|
Catheter Site Phlebitis
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Cyst
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Death
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
Device Intolerance
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Discomfort
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Drowning
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
2 / 6939 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 2 |
Malaise
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Medical Device Complication
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Pyrexia
|
|
|
subjects affected / exposed
|
9 / 13915 (0.06%) |
2 / 6939 (0.03%) |
occurrences causally related to treatment / all
|
0 / 9 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Soft Tissue Inflammation
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Sudden Death
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 2 |
0 / 0 |
Immune system disorders
|
|
|
Allergy To Arthropod Sting
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Anaphylactic Reaction
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Anti-Neutrophil Cytoplasmic Antibody Positive Vasculitis
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
Antiphospholipid Syndrome
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Drug Hypersensitivity
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
2 / 6939 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Food Allergy
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Social circumstances
|
|
|
Physical Assault
|
|
|
subjects affected / exposed
|
9 / 13915 (0.06%) |
4 / 6939 (0.06%) |
occurrences causally related to treatment / all
|
0 / 9 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Sexual Abuse
|
|
|
subjects affected / exposed
|
7 / 13915 (0.05%) |
4 / 6939 (0.06%) |
occurrences causally related to treatment / all
|
0 / 7 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Substance Use
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Victim Of Crime
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Victim Of Homicide
|
|
|
subjects affected / exposed
|
5 / 13915 (0.04%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 5 |
0 / 1 |
Victim Of Sexual Abuse
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Reproductive system and breast disorders
|
|
|
Adenomyosis
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Balanitis
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Bartholinitis
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Breast Disorder
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Breast Mass
|
|
|
subjects affected / exposed
|
4 / 13915 (0.03%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Breast Pain
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Coital Bleeding
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Dysfunctional Uterine Bleeding
|
|
|
subjects affected / exposed
|
3 / 13915 (0.02%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Dysmenorrhoea
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Endometriosis
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Epididymitis
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Female Genital Tract Fistula
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Gynaecomastia
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Haematocolpos
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Haematosalpinx
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Haemorrhagic Ovarian Cyst
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Metrorrhagia
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Ovarian Cyst
|
|
|
subjects affected / exposed
|
7 / 13915 (0.05%) |
5 / 6939 (0.07%) |
occurrences causally related to treatment / all
|
0 / 7 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Ovarian Cyst Ruptured
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Ovarian Torsion
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Ovulation Pain
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Pelvic Pain
|
|
|
subjects affected / exposed
|
3 / 13915 (0.02%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Polycystic Ovaries
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Retrograde Menstruation
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Testicular Disorder
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Testicular Torsion
|
|
|
subjects affected / exposed
|
12 / 13915 (0.09%) |
3 / 6939 (0.04%) |
occurrences causally related to treatment / all
|
0 / 12 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Uterine Cyst
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Uterine Haemorrhage
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Vaginal Haemorrhage
|
|
|
subjects affected / exposed
|
3 / 13915 (0.02%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Varicocele
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Vulval Haematoma
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Respiratory, thoracic and mediastinal disorders
|
|
|
Acute Pulmonary Oedema
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
Acute Respiratory Failure
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
Adenoidal Hypertrophy
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Alveolitis Allergic
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Asphyxia
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 2 |
0 / 0 |
Aspiration
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
Asthma
|
|
|
subjects affected / exposed
|
19 / 13915 (0.14%) |
17 / 6939 (0.24%) |
occurrences causally related to treatment / all
|
1 / 24 |
0 / 22 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Asthmatic Crisis
|
|
|
subjects affected / exposed
|
12 / 13915 (0.09%) |
7 / 6939 (0.10%) |
occurrences causally related to treatment / all
|
0 / 14 |
0 / 8 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Bronchial Obstruction
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Epistaxis
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Haemothorax
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Nasal Septum Deviation
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Nasal Turbinate Hypertrophy
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Oropharyngeal Pain
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Pleurisy
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Pneumothorax
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Pulmonary Artery Stenosis
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Pulmonary Embolism
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Pulmonary Oedema
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
Respiratory Tract Haemorrhage
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Status Asthmaticus
|
|
|
subjects affected / exposed
|
5 / 13915 (0.04%) |
2 / 6939 (0.03%) |
occurrences causally related to treatment / all
|
0 / 6 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Tonsillar Cyst
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Tonsillar Hypertrophy
|
|
|
subjects affected / exposed
|
5 / 13915 (0.04%) |
2 / 6939 (0.03%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Psychiatric disorders
|
|
|
Abnormal Behaviour
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Acute Psychosis
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Acute Stress Disorder
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Adjustment Disorder
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Aggression
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Anorexia Nervosa
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Anxiety Disorder
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Bipolar I Disorder
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Bipolar Disorder
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
3 / 6939 (0.04%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Completed Suicide
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
2 / 6939 (0.03%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 2 |
0 / 2 |
Conduct Disorder
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Conversion Disorder
|
|
|
subjects affected / exposed
|
3 / 13915 (0.02%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Dependence
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Depression
|
|
|
subjects affected / exposed
|
18 / 13915 (0.13%) |
9 / 6939 (0.13%) |
occurrences causally related to treatment / all
|
0 / 18 |
0 / 9 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Depression Suicidal
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
2 / 6939 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Dissociative Disorder
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Drug Abuse
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Drug Dependence
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Intentional Drug Misuse
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Intentional Self-Injury
|
|
|
subjects affected / exposed
|
6 / 13915 (0.04%) |
2 / 6939 (0.03%) |
occurrences causally related to treatment / all
|
0 / 6 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Intermittent Explosive Disorder
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Major Depression
|
|
|
subjects affected / exposed
|
6 / 13915 (0.04%) |
2 / 6939 (0.03%) |
occurrences causally related to treatment / all
|
0 / 6 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Obsessive Rumination
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Psychotic Disorder
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Schizophrenia
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
2 / 6939 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Schizophrenia, Undifferentiated Type
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Somatoform Disorder
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Substance Abuse
|
|
|
subjects affected / exposed
|
14 / 13915 (0.10%) |
9 / 6939 (0.13%) |
occurrences causally related to treatment / all
|
0 / 15 |
0 / 13 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Suicidal Ideation
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Suicide Attempt
|
|
|
subjects affected / exposed
|
19 / 13915 (0.14%) |
8 / 6939 (0.12%) |
occurrences causally related to treatment / all
|
0 / 19 |
0 / 14 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Hepatobiliary disorders
|
|
|
Autoimmune Hepatitis
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Bile Duct Stone
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Cholecystitis
|
|
|
subjects affected / exposed
|
7 / 13915 (0.05%) |
6 / 6939 (0.09%) |
occurrences causally related to treatment / all
|
0 / 7 |
0 / 6 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Cholecystitis Acute
|
|
|
subjects affected / exposed
|
5 / 13915 (0.04%) |
2 / 6939 (0.03%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Cholecystitis Chronic
|
|
|
subjects affected / exposed
|
3 / 13915 (0.02%) |
2 / 6939 (0.03%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Cholelithiasis
|
|
|
subjects affected / exposed
|
9 / 13915 (0.06%) |
13 / 6939 (0.19%) |
occurrences causally related to treatment / all
|
0 / 9 |
0 / 15 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Cholestasis Of Pregnancy
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Gallbladder Disorder
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Hepatitis
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Hepatitis Acute
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Hepatitis Toxic
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Hydrocholecystis
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Jaundice
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
2 / 6939 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Investigations
|
|
|
Investigation
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Injury, poisoning and procedural complications
|
|
|
Abdominal Injury
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Accident
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Accident At Home
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Accident At Work
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Acetabulum Fracture
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Adverse Event Following Immunisation
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Alcohol Poisoning
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Animal Bite
|
|
|
subjects affected / exposed
|
3 / 13915 (0.02%) |
3 / 6939 (0.04%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Ankle Fracture
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Arthropod Sting
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Avulsion Fracture
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Burns Second Degree
|
|
|
subjects affected / exposed
|
6 / 13915 (0.04%) |
2 / 6939 (0.03%) |
occurrences causally related to treatment / all
|
0 / 6 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Burns Third Degree
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Chemical Poisoning
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Chest Injury
|
|
|
subjects affected / exposed
|
3 / 13915 (0.02%) |
2 / 6939 (0.03%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
Clavicle Fracture
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Endotracheal Intubation Complication
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Epiphyseal Fracture
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Eye Injury
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Eye Penetration
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Face Injury
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Facial Bones Fracture
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Fall
|
|
|
subjects affected / exposed
|
28 / 13915 (0.20%) |
11 / 6939 (0.16%) |
occurrences causally related to treatment / all
|
0 / 28 |
0 / 12 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
Femur Fracture
|
|
|
subjects affected / exposed
|
5 / 13915 (0.04%) |
2 / 6939 (0.03%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Fibula Fracture
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Foot Fracture
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
2 / 6939 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Forearm Fracture
|
|
|
subjects affected / exposed
|
21 / 13915 (0.15%) |
7 / 6939 (0.10%) |
occurrences causally related to treatment / all
|
0 / 21 |
0 / 7 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Foreign Body
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
3 / 6939 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Foreign Body In Eye
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Genital Injury
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Gun Shot Wound
|
|
|
subjects affected / exposed
|
24 / 13915 (0.17%) |
15 / 6939 (0.22%) |
occurrences causally related to treatment / all
|
0 / 24 |
0 / 15 |
deaths causally related to treatment / all
|
0 / 12 |
0 / 9 |
Hand Fracture
|
|
|
subjects affected / exposed
|
5 / 13915 (0.04%) |
3 / 6939 (0.04%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Head Injury
|
|
|
subjects affected / exposed
|
16 / 13915 (0.11%) |
3 / 6939 (0.04%) |
occurrences causally related to treatment / all
|
0 / 17 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
Humerus Fracture
|
|
|
subjects affected / exposed
|
6 / 13915 (0.04%) |
5 / 6939 (0.07%) |
occurrences causally related to treatment / all
|
0 / 6 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Injury
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Intentional Overdose
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Joint Dislocation
|
|
|
subjects affected / exposed
|
3 / 13915 (0.02%) |
2 / 6939 (0.03%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Joint Injury
|
|
|
subjects affected / exposed
|
5 / 13915 (0.04%) |
2 / 6939 (0.03%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Limb Crushing Injury
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Limb Injury
|
|
|
subjects affected / exposed
|
4 / 13915 (0.03%) |
3 / 6939 (0.04%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Limb Traumatic Amputation
|
|
|
subjects affected / exposed
|
4 / 13915 (0.03%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Lower Limb Fracture
|
|
|
subjects affected / exposed
|
3 / 13915 (0.02%) |
3 / 6939 (0.04%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Lumbar Vertebral Fracture
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Meniscus Lesion
|
|
|
subjects affected / exposed
|
3 / 13915 (0.02%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Multiple Fractures
|
|
|
subjects affected / exposed
|
6 / 13915 (0.04%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 6 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Multiple Injuries
|
|
|
subjects affected / exposed
|
12 / 13915 (0.09%) |
3 / 6939 (0.04%) |
occurrences causally related to treatment / all
|
0 / 12 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 2 |
0 / 0 |
Muscle Injury
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Nerve Injury
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Open Wound
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Perineal Laceration
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Pneumothorax Traumatic
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Poisoning
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Poisoning Deliberate
|
|
|
subjects affected / exposed
|
15 / 13915 (0.11%) |
10 / 6939 (0.14%) |
occurrences causally related to treatment / all
|
0 / 16 |
0 / 10 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
Post Procedural Haemorrhage
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Post-Traumatic Pain
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Postoperative Wound Complication
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Procedural Complication
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Radius Fracture
|
|
|
subjects affected / exposed
|
8 / 13915 (0.06%) |
3 / 6939 (0.04%) |
occurrences causally related to treatment / all
|
0 / 8 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Road Traffic Accident
|
|
|
subjects affected / exposed
|
108 / 13915 (0.78%) |
39 / 6939 (0.56%) |
occurrences causally related to treatment / all
|
0 / 109 |
0 / 39 |
deaths causally related to treatment / all
|
0 / 5 |
0 / 5 |
Skull Fracture
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Soft Tissue Injury
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Spinal Cord Injury
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Spinal Cord Injury Cervical
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
Sports Injury
|
|
|
subjects affected / exposed
|
8 / 13915 (0.06%) |
3 / 6939 (0.04%) |
occurrences causally related to treatment / all
|
0 / 8 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Stab Wound
|
|
|
subjects affected / exposed
|
5 / 13915 (0.04%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Tendon Injury
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Tendon Rupture
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Testicular Injury
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Thermal Burn
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Tibia Fracture
|
|
|
subjects affected / exposed
|
5 / 13915 (0.04%) |
3 / 6939 (0.04%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Toxicity To Various Agents
|
|
|
subjects affected / exposed
|
7 / 13915 (0.05%) |
4 / 6939 (0.06%) |
occurrences causally related to treatment / all
|
0 / 7 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
Traumatic Brain Injury
|
|
|
subjects affected / exposed
|
5 / 13915 (0.04%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
Traumatic Fracture
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Ulna Fracture
|
|
|
subjects affected / exposed
|
3 / 13915 (0.02%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Ulnar Nerve Injury
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Upper Limb Fracture
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Vascular Access Complication
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Wound
|
|
|
subjects affected / exposed
|
5 / 13915 (0.04%) |
2 / 6939 (0.03%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Wrist Fracture
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Congenital, familial and genetic disorders
|
|
|
Arteriovenous Malformation
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Atrial Septal Defect
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Cryptorchism
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Hereditary Spherocytosis
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Phimosis
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
3 / 6939 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Sickle Cell Trait
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Cardiac disorders
|
|
|
Tachycardia
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Wolff-Parkinson-White Syndrome
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Nervous system disorders
|
|
|
Acute Disseminated Encephalomyelitis
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Acute Polyneuropathy
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Arachnoid Cyst
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Atonic Seizures
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Cerebellar Syndrome
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Complicated Migraine
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Convulsion
|
|
|
subjects affected / exposed
|
21 / 13915 (0.15%) |
10 / 6939 (0.14%) |
occurrences causally related to treatment / all
|
0 / 31 |
0 / 11 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Dizziness
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Encephalitis
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
Epilepsy
|
|
|
subjects affected / exposed
|
26 / 13915 (0.19%) |
8 / 6939 (0.12%) |
occurrences causally related to treatment / all
|
0 / 86 |
0 / 27 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
Grand Mal Convulsion
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
2 / 6939 (0.03%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Guillain-Barre Syndrome
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
2 / 6939 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Haemorrhage Intracranial
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
Haemorrhagic Cerebral Infarction
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Headache
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
2 / 6939 (0.03%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Hydrocephalus
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Hypersomnia
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Hypertensive Encephalopathy
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Idiopathic Generalised Epilepsy
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Intracranial Aneurysm
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Migraine
|
|
|
subjects affected / exposed
|
5 / 13915 (0.04%) |
2 / 6939 (0.03%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Migraine With Aura
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Migraine Without Aura
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Neuropathy Peripheral
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Partial Seizures
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Post-Traumatic Headache
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Status Epilepticus
|
|
|
subjects affected / exposed
|
3 / 13915 (0.02%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Status Migrainosus
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Syncope
|
|
|
subjects affected / exposed
|
6 / 13915 (0.04%) |
2 / 6939 (0.03%) |
occurrences causally related to treatment / all
|
0 / 6 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Viith Nerve Paralysis
|
|
|
subjects affected / exposed
|
5 / 13915 (0.04%) |
3 / 6939 (0.04%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Blood and lymphatic system disorders
|
|
|
Anaemia
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
4 / 6939 (0.06%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Anaemia Of Pregnancy
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Aplastic Anaemia
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Haemorrhagic Anaemia
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Idiopathic Thrombocytopenic Purpura
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Iron Deficiency Anaemia
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Lymphadenitis
|
|
|
subjects affected / exposed
|
7 / 13915 (0.05%) |
4 / 6939 (0.06%) |
occurrences causally related to treatment / all
|
0 / 7 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Lymphadenopathy
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Lymphoid Tissue Hyperplasia
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Thrombocytopenia
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Thrombocytopenic Purpura
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Ear and labyrinth disorders
|
|
|
Tympanic Membrane Perforation
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Vertigo
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Eye disorders
|
|
|
Keratoconus
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Retinal Detachment
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Visual Impairment
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Gastrointestinal disorders
|
|
|
Abdominal Adhesions
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Abdominal Pain
|
|
|
subjects affected / exposed
|
26 / 13915 (0.19%) |
9 / 6939 (0.13%) |
occurrences causally related to treatment / all
|
0 / 26 |
0 / 9 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Abdominal Pain Lower
|
|
|
subjects affected / exposed
|
3 / 13915 (0.02%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Abdominal Pain Upper
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Acute Abdomen
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Anal Haemorrhage
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Colitis
|
|
|
subjects affected / exposed
|
3 / 13915 (0.02%) |
4 / 6939 (0.06%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Constipation
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Diarrhoea
|
|
|
subjects affected / exposed
|
5 / 13915 (0.04%) |
4 / 6939 (0.06%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Dyspepsia
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Enteritis
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Enterocolitis
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Faecaloma
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Food Poisoning
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
2 / 6939 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Gastritis
|
|
|
subjects affected / exposed
|
12 / 13915 (0.09%) |
5 / 6939 (0.07%) |
occurrences causally related to treatment / all
|
0 / 13 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Gastritis Haemorrhagic
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Gastrointestinal Haemorrhage
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Gingivitis
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Haematemesis
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Inguinal Hernia
|
|
|
subjects affected / exposed
|
5 / 13915 (0.04%) |
2 / 6939 (0.03%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Inguinal Hernia, Obstructive
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Intestinal Functional Disorder
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Intestinal Obstruction
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
3 / 6939 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Intussusception
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Irritable Bowel Syndrome
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Malocclusion
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Pancreatitis
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Pancreatitis Acute
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
2 / 6939 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Peptic Ulcer
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Peritonitis
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Stomatitis
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Umbilical Hernia
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Umbilical Hernia, Obstructive
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Varices Oesophageal
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Vomiting
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Vomiting In Pregnancy
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Skin and subcutaneous tissue disorders
|
|
|
Angioedema
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Dermatitis Atopic
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Erythema
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Erythema Nodosum
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Henoch-Schonlein Purpura
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Hypertrophic Scar
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Mechanical Urticaria
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Rash Erythematous
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Skin Fissures
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Subcutaneous Nodule
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Urticaria
|
|
|
subjects affected / exposed
|
4 / 13915 (0.03%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
1 / 4 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Renal and urinary disorders
|
|
|
Calculus Ureteric
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Calculus Urethral
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Calculus Urinary
|
|
|
subjects affected / exposed
|
3 / 13915 (0.02%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Cystitis Haemorrhagic
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Glomerulonephritis
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Haematuria
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Lupus Nephritis
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
Nephritic Syndrome
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Nephrolithiasis
|
|
|
subjects affected / exposed
|
15 / 13915 (0.11%) |
5 / 6939 (0.07%) |
occurrences causally related to treatment / all
|
0 / 15 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Post Streptococcal Glomerulonephritis
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Renal Colic
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
3 / 6939 (0.04%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Renal Failure
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Renal Tubular Necrosis
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Tubulointerstitial Nephritis
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Urogenital Haemorrhage
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Endocrine disorders
|
|
|
Basedow's Disease
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Hypothalamo-Pituitary Disorder
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Musculoskeletal and connective tissue disorders
|
|
|
Ankle Deformity
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Arthropathy
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Back Pain
|
|
|
subjects affected / exposed
|
4 / 13915 (0.03%) |
2 / 6939 (0.03%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Epiphysiolysis
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Intervertebral Disc Protrusion
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Juvenile Arthritis
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
2 / 6939 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Knee Deformity
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Myopathy
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Myositis
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Pathological Fracture
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Rhabdomyolysis
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Rheumatic Fever
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Rheumatoid Arthritis
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Sacroiliitis
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Synovial Cyst
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Systemic Lupus Erythematosus
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
2 / 6939 (0.03%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Infections and infestations
|
|
|
Abdominal Abscess
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Abortion Infected
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
2 / 6939 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Abscess
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Abscess Limb
|
|
|
subjects affected / exposed
|
6 / 13915 (0.04%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 6 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Abscess Neck
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Abscess Of Salivary Gland
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Abscess Oral
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
2 / 6939 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Acute Sinusitis
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Acute Tonsillitis
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
4 / 6939 (0.06%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Adenoiditis
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Amniotic Cavity Infection
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Amoebiasis
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Amoebic Dysentery
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Anal Abscess
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Anogenital Warts
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Appendicitis
|
|
|
subjects affected / exposed
|
261 / 13915 (1.88%) |
138 / 6939 (1.99%) |
occurrences causally related to treatment / all
|
0 / 261 |
0 / 138 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Appendicitis Perforated
|
|
|
subjects affected / exposed
|
5 / 13915 (0.04%) |
2 / 6939 (0.03%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Arthritis Bacterial
|
|
|
subjects affected / exposed
|
3 / 13915 (0.02%) |
2 / 6939 (0.03%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Arthritis Infective
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Asymptomatic Hiv Infection
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Bacterial Infection
|
|
|
subjects affected / exposed
|
3 / 13915 (0.02%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Bartholin's Abscess
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
3 / 6939 (0.04%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Breast Abscess
|
|
|
subjects affected / exposed
|
4 / 13915 (0.03%) |
3 / 6939 (0.04%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Breast Cellulitis
|
|
|
subjects affected / exposed
|
6 / 13915 (0.04%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 6 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Bronchiolitis
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Bronchitis
|
|
|
subjects affected / exposed
|
8 / 13915 (0.06%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 8 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Bronchopneumonia
|
|
|
subjects affected / exposed
|
6 / 13915 (0.04%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 6 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Carbuncle
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Cellulitis
|
|
|
subjects affected / exposed
|
50 / 13915 (0.36%) |
35 / 6939 (0.50%) |
occurrences causally related to treatment / all
|
0 / 50 |
0 / 35 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Chikungunya Virus Infection
|
|
|
subjects affected / exposed
|
8 / 13915 (0.06%) |
3 / 6939 (0.04%) |
occurrences causally related to treatment / all
|
0 / 8 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Chorioamnionitis
|
|
|
subjects affected / exposed
|
3 / 13915 (0.02%) |
2 / 6939 (0.03%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Chronic Sinusitis
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Chronic Tonsillitis
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
2 / 6939 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Cutaneous Anthrax
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Cystitis
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Dengue Fever
|
|
|
subjects affected / exposed
|
101 / 13915 (0.73%) |
94 / 6939 (1.35%) |
occurrences causally related to treatment / all
|
0 / 104 |
0 / 94 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Endometritis
|
|
|
subjects affected / exposed
|
3 / 13915 (0.02%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Endometritis Decidual
|
|
|
subjects affected / exposed
|
3 / 13915 (0.02%) |
2 / 6939 (0.03%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Enterocolitis Infectious
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Erysipelas
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
3 / 6939 (0.04%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
External Ear Cellulitis
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Eye Infection Toxoplasmal
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Flavivirus Infection
|
|
|
subjects affected / exposed
|
3 / 13915 (0.02%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Gastroenteritis
|
|
|
subjects affected / exposed
|
34 / 13915 (0.24%) |
21 / 6939 (0.30%) |
occurrences causally related to treatment / all
|
0 / 34 |
0 / 21 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Gastroenteritis Bacterial
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Gastroenteritis Viral
|
|
|
subjects affected / exposed
|
3 / 13915 (0.02%) |
2 / 6939 (0.03%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Gastrointestinal Bacterial Infection
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Gastrointestinal Infection
|
|
|
subjects affected / exposed
|
3 / 13915 (0.02%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Gastrointestinal Viral Infection
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Genital Infection Female
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Genitourinary Tract Infection
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
2 / 6939 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Granuloma Inguinale
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
H1n1 Influenza
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Hiv Infection
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Hiv Infection Cdc Category A3
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Helminthic Infection
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Hepatitis A
|
|
|
subjects affected / exposed
|
3 / 13915 (0.02%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Hepatitis Viral
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Herpes Zoster
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Herpes Zoster Ophthalmic
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Infected Bites
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Infectious Mononucleosis
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Infective Myositis
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Influenza
|
|
|
subjects affected / exposed
|
3 / 13915 (0.02%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Leptospirosis
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Lower Respiratory Tract Infection
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Lung Infection
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Malaria
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Mastitis
|
|
|
subjects affected / exposed
|
4 / 13915 (0.03%) |
3 / 6939 (0.04%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Mastitis Postpartum
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
3 / 6939 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Mastoiditis
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Meningitis Bacterial
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Meningitis Viral
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Mononucleosis Syndrome
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Mumps
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Mycoplasma Infection
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Nasopharyngitis
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
2 / 6939 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Orchitis
|
|
|
subjects affected / exposed
|
5 / 13915 (0.04%) |
2 / 6939 (0.03%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Osteomyelitis
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Osteomyelitis Chronic
|
|
|
subjects affected / exposed
|
4 / 13915 (0.03%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Otitis Media
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
2 / 6939 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Otitis Media Chronic
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Pancreatitis Mumps
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Panencephalitis
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
Parasitic Gastroenteritis
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Pelvic Inflammatory Disease
|
|
|
subjects affected / exposed
|
10 / 13915 (0.07%) |
4 / 6939 (0.06%) |
occurrences causally related to treatment / all
|
0 / 11 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Perineal Abscess
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Perineal Infection
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Periorbital Cellulitis
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Peritonsillar Abscess
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
2 / 6939 (0.03%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Pharyngotonsillitis
|
|
|
subjects affected / exposed
|
3 / 13915 (0.02%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Pilonidal Cyst
|
|
|
subjects affected / exposed
|
5 / 13915 (0.04%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 6 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Pneumonia
|
|
|
subjects affected / exposed
|
18 / 13915 (0.13%) |
13 / 6939 (0.19%) |
occurrences causally related to treatment / all
|
0 / 18 |
0 / 13 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Pneumonia Bacterial
|
|
|
subjects affected / exposed
|
4 / 13915 (0.03%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Pneumonia Mycoplasmal
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Post Procedural Infection
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Postoperative Wound Infection
|
|
|
subjects affected / exposed
|
6 / 13915 (0.04%) |
4 / 6939 (0.06%) |
occurrences causally related to treatment / all
|
0 / 8 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Postpartum Sepsis
|
|
|
subjects affected / exposed
|
4 / 13915 (0.03%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Pulmonary Tuberculosis
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Pyelonephritis
|
|
|
subjects affected / exposed
|
10 / 13915 (0.07%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 12 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Pyelonephritis Acute
|
|
|
subjects affected / exposed
|
7 / 13915 (0.05%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 7 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Retroperitoneal Abscess
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Salmonellosis
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Scarlet Fever
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Secondary Syphilis
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Sepsis
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Sinusitis
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Skin Infection
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Soft Tissue Infection
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Subcutaneous Abscess
|
|
|
subjects affected / exposed
|
13 / 13915 (0.09%) |
2 / 6939 (0.03%) |
occurrences causally related to treatment / all
|
0 / 13 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Syphilis
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Tonsillitis
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
2 / 6939 (0.03%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Tonsillitis Bacterial
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Tooth Abscess
|
|
|
subjects affected / exposed
|
6 / 13915 (0.04%) |
2 / 6939 (0.03%) |
occurrences causally related to treatment / all
|
0 / 6 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Toxoplasmosis
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
2 / 6939 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Tracheitis
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Tuberculosis
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Typhoid Fever
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Upper Respiratory Tract Infection
|
|
|
subjects affected / exposed
|
3 / 13915 (0.02%) |
3 / 6939 (0.04%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Urinary Tract Infection
|
|
|
subjects affected / exposed
|
118 / 13915 (0.85%) |
59 / 6939 (0.85%) |
occurrences causally related to treatment / all
|
0 / 127 |
0 / 69 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Urinary Tract Infection Bacterial
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Urosepsis
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Vaginal Infection
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Varicella
|
|
|
subjects affected / exposed
|
3 / 13915 (0.02%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Viral Cardiomyopathy
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Viral Infection
|
|
|
subjects affected / exposed
|
10 / 13915 (0.07%) |
7 / 6939 (0.10%) |
occurrences causally related to treatment / all
|
0 / 10 |
0 / 7 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Visceral Leishmaniasis
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Vulval Abscess
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Wound Infection
|
|
|
subjects affected / exposed
|
5 / 13915 (0.04%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Metabolism and nutrition disorders
|
|
|
Dehydration
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Diabetes Mellitus Inadequate Control
|
|
|
subjects affected / exposed
|
0 / 13915 (0.00%) |
2 / 6939 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Diabetic Ketoacidosis
|
|
|
subjects affected / exposed
|
2 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Hypoglycaemia
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
0 / 6939 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Type 1 Diabetes Mellitus
|
|
|
subjects affected / exposed
|
1 / 13915 (0.01%) |
1 / 6939 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |